Granite Asia

Granite Asia is the rebranded Asian arm of GGV Capital, operating as a multi-asset platform that targets health innovation and wellness companies scaling across the Asia-Pacific region. The firm runs from Singapore and inherits the GGV Asia investment book, which gives it both a substantial existing portfolio and well-developed relationships with co-investors across the region. Healthcare exposure concentrates on digital health and care delivery and tech-enabled services.

The thesis is built around the observation that APAC healthcare and consumer wellness markets are large, fragmented, and digitizing rapidly, and that companies with strong technology, operational discipline, and regional ambition can build category-defining businesses. Granite Asia is positioned to support those companies from seed through growth, which is unusual in a region where most firms specialize at one stage. Healthcare investments under this thesis tend to be tech-enabled service businesses, digital health platforms, and AI-driven consumer wellness companies with credible regional or pan-APAC ambitions.

The firm writes checks generally between $5M and $25M, operating across seed, Series A, Series B, and growth rounds. That stage flexibility, combined with check sizes that allow it to lead at later stages, makes Granite Asia an unusual partner that can support a company from initial institutional financing through pre-IPO. Geographically, the focus is APAC with particular density in Singapore, Greater China, India, and Southeast Asia. The firm is comfortable backing companies that need to operate across multiple Asian jurisdictions, which is often a structural challenge for healthcare and wellness businesses.

The team is built from former GGV Asia partners and operating professionals, with deep regional experience and existing relationships with founders, co-investors, and corporate partners across APAC. That continuity matters for portfolio companies, since the people leading diligence are typically the same ones who held positions during the GGV era and have observed multiple cycles in the region.

In working with companies, Granite Asia’s most distinctive value is its multi-jurisdictional regional reach, including support for cross-border expansion within APAC, regulatory navigation across multiple healthcare systems, and connections into corporate partners and follow-on investors in each major regional market. The firm helps with growth-stage hiring and with structuring later rounds with global investors. For healthcare founders, the fit is strongest for companies with credible regional ambition, technology-driven business models, and the operational maturity to manage cross-border expansion. The fit is weaker for single-market businesses or for biotech and pure life sciences companies that require the deeper regulatory specialism of a sector-focused fund. Founders considering Granite Asia should plan for an institutional process and should bring a clear articulation of how the firm’s regional reach will accelerate their cross-border expansion.